Pain Therapeutics (PTIE) Tops Q3 EPS by 1c
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Pain Therapeutics (NASDAQ: PTIE) reported Q3 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09).
At September 30, 2016, cash and investments were $21.8 million, compared to $24.6 million at June 30, 2016. The Company has no debt.
For earnings history and earnings-related data on Pain Therapeutics (PTIE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AutoZone (AZO) Tops Q1 EPS by 5c; Comps Light of Views
- TerraForm Power (TERP) Posts Q1 Loss of 1c/Share
- XTL Biopharma (XTLB) Posts Breakeven Q3 Loss
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!